The waiting.
Oh, the waiting.

Sometimes systems fail. If you experience a technical error, please report it. We understand that mistakes happen. Try not to panic and get in touch. You can email Leanne directly at leanne@wearemorehuman.co.uk. Please briefly describe the problem (screenshots help) and we will do our best to help you solve it.

All sales are final, as your brain‑body profile and self-reports are available instantly. Please be sure you understand the service before you upgrade to paid.

Uma launched globally on 9 October 2026.

Uma is available globally.

Yes. Uma is committed to maintaining your privacy and helping women safely self-screen. We do not sell personally identifiable health data to third parties. Uma is GDPR compliant and uses two-factor authentication.

Beyond your email login and full name, Uma does not collect any personal identifiers, such as your address, telephone number or date of birth. Your self-reports are anonymised and all health information is de-identified of any personal identifiers.

Our third-party provider, Stripe, handles payment. We are not privy to any personal details you share with them.

Yes, Uma is fully GDPR compliant. We are committed to protecting your personal data and privacy in accordance with the General Data Protection Regulation (GDPR).

Yes, Uma is HIPAA compliant.

Adult women, non‑binary and AFAB people who want to self-identify as ADHD or autistic.

Uma is not designed to support:

• Children: You must be 18 or older to use this service.
• Cisgender men: Uma is attuned to look for key differences in how autism and ADHD present across sex and gender. The service was co-designed with and for women, non‑binary and AFAB people. At this time we are not set up to support cisgender men. We welcome trans women.

No. Uma is a self-identification and screening service, not a diagnostic test or formal assessment. Only a trained health professional can provide a medical diagnosis of autism, ADHD or CPTSD. Uma can offer an indication of whether you might meet clinical thresholds based on your self-reported traits and symptoms, helping you to decide whether to proceed with a medical diagnosis. This does not guarantee a medical diagnosis.

Individually, the autism, ADHD and CPTSD screenings take 15 minutes or less. Uma will score you in real time and share your scores for each section, so there are no big surprises at the end. You will get answers in minutes. You can also use voice input to speed through the screenings.

Uma was co-designed with, and for, women, non‑binary and AFAB people. Our questions are based on the latest research into how autism and ADHD present in these populations, which is often different from the male-centric criteria used in traditional diagnostic tools.

Uma looks for known sex and gender differences, such as higher masking, rejection sensitivity, rumination, emotional dysregulation, as well as co-occurring depression, anxiety, CPTSD, and somatic symptoms related to traumatic stress, mast cell activation syndrome (MCAS) and hypermobile EDS (hEDS).

Uma is attuned to look for key differences in how autism and ADHD present across sex and gender. For example, we know that women and AFAB people are more likely to repress the urge to fidget or engage in subtle, small, repetitive movements (stimming), such as playing with their hair, jewellery or doodling. This could be because of masking or sex differences in how the motor system develops ¹². While boys tend to develop stronger gross motor skills and explosive movement, girls tend to outperform boys in fine motor skills and detail tasks.

See also: Musálek et al., 2020¹³; Surgent et al., 2025¹⁴; Xiaoyu et al., 2023¹⁵

We also look for divergence from what is most commonly reported by cisgender women, ensuring we account for the full spectrum of differences. For example, we know autistic women are more likely to experience sensory hypersensitivity and overload than men, reflecting sex differences in the autonomic nervous system ¹⁶ seen in the general population. However, people with conditions like anorexia ¹⁷, PCOS ¹⁸ or diabetes ¹⁹ are more likely to experience sensory blunting (also known as diabetic neuropathy ²⁰) and co-occurring alexithymia. Both PCOS ²¹ and diabetes ²² are also more commonly reported by people who have experienced gender dysphoria or identify as trans. Around half of people with PCOS develop diabetes before age 40.

Uma was researched, co-designed, and tested with over 1,000 people from across the world. We are following a human-centred design process, starting with the voice of lived experience. Rather than a group of clinicians in a room brainstorming statements about how autism and ADHD present in women, we undertook primary research into how neurodivergent women experience autism and ADHD. We built the screenings from this data before testing them with participants. We will continue to test and iterate the service in response to feedback until we get it right.

The screenings have been validated with over 1,000 neurodivergent people from across the globe. We will continue to refine the screenings in response to feedback. The final step will be a peer-reviewed study with a neurotypical control group, which is considered the gold standard for psychometric validation.

Self-identification is when a person identifies as autistic without having a formal clinical diagnosis. The term "self-diagnosis" is also used, particularly in the media. This is a common choice for many people, who may be waiting for an assessment or may choose it as an alternative to seeking one at all.

• It's empowering. The number one benefit is claiming your neurodivergent identity and discovering who you are by gaining understanding and explanation.

• It's fast. While a formal diagnosis can take years, a self-report can give you answers in minutes.

• It's free. A formal diagnosis can cost up to £3,500, whereas self-identification costs nothing.

• It helps you access support. A medical diagnosis is not required to access many services or to ask for workplace adjustments in the UK. This is a common misconception. You can begin to access support as soon as you self-identify.

• There is no treatment. There is no cure for autism. As a result, many of the support options available with an official diagnosis are also readily available through self-identification.

• It helps you avoid an official mark on your medical records, which many people fear due to the risk of stigma and discrimination.

• Continued uncertainty. You may experience continued uncertainty and second-guess yourself, which is a key reason many people choose to seek an official medical diagnosis.

• Continued invalidation. Your self-identification may be questioned by friends, family, employers, or medical professionals, which can be frustrating and lead to continued invalidation.

• Criticism of "self-diagnosis". "Self-diagnosis" is frequently criticised in the media, which suggests that autistic people use platforms like TikTok to "self-diagnose". Uma is different because it provides an evidence-based screening service that allows you to confidently self-identify with ADHD, autism or CPTSD and choose to get a medical diagnosis if it's right for you.